Guy Hatchard: Business as Usual is a Miscarriage of Justice

Another among hundreds of novel biotech vaccines currently under development for a range of diseases has gained approval from the US FDA. 

Abrysvo is Pfizer’s vaccine for the prevention of respiratory syncytial virus (RSV) in infants through active immunisation of pregnant women at 32-36 weeks of gestational age.